An E-health Letter Intervention for Caregivers (90Second)

IWK Health Centre

Status: Enrolling

Conditions: Acquired Brain Injury; Caregivers

Treatments: Behavioral: 90Second Caregiver health letter

Study type: Interventional

Funder types: Other

Identifiers

NCT05882461

1025834

Details and patient eligibility

About

The purpose of the present study is to conduct a two-arm Randomized Control Trial (RCT) comparing individuals receiving the 90Second Caregiver health letter, with a usual care (routine care received by caregivers) control group.

The goals of the present study are:

• To evaluate the effectiveness of the 90Second Caregiver health letter in improving caregiver's self-efficacy (primary outcome), savouring, and quality of life (secondary outcomes).
• To evaluate the effectiveness of the 90Second Caregiver health letter in reducing caregiver's psychological strain and caregiver burden (secondary outcomes).
• To examine the impact of levels of engagement with the 90Second Caregiver health letter on primary and secondary outcomes.
• To assess the usability of the 90Second Caregiver health letter, as it relates to the relevance of topic, user friendliness, and appropriateness of the readability levels.
• To evaluate psychometric properties of self-constructed measures in 90Second newsletter.

Full description

The present study will examine the effectiveness of the 90Second Caregiver health letter in increasing self-efficacy in a sample of informal caregivers of ABI survivors in Nova Scotia. Participants in this study will be recruited from the Caring Forward Trials within Cohort Study (REB#1025253). The study is funded by the Nova Scotia Department of Health and Wellness.

Enrollment: 330 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant is currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
• Participant has agreed to be contacted for future studies by Dr. McGrath's staff
• Participant has agreed for their data to be used for future studies
• Participant has mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF

Exclusion criteria

• Participant is NOT currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
• Participant has NOT agreed to be contacted for future studies by Dr. McGrath's staff
• Participant has NOT agreed for their data to be used in future studies
• Participant does NOT report mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

330 participants in 2 patient groups

Those receiving the 90Second Caregiver health letter

Experimental group

Description:

The 90Second Caregiver health letter is a weekly online publication that addresses topics relevant for caregivers. It combines scientifically-valid, evidence-based information with actionable tips to improve caregiver self efficacy and well-being. Participant in this group will receive a 90Second Caregiver health letter every week, via email.

Treatment:

Behavioral: 90Second Caregiver health letter

The usual care control group

No Intervention group

Description:

Participants that are randomized to be in the usual care control group will continue on as participants in the Caring Forward Trials within Cohort Study (i.e. filling out questionnaires every 6-months). Participants will continue to participate in the Caring Forward Study until completion in March 2022.